Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 322.63M P/E - EPS this Y 15.90% Ern Qtrly Grth -
Income -110.78M Forward P/E -3.43 EPS next Y 16.70% 50D Avg Chg -5.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -1.00%
Dividend N/A Price/Book 3.94 EPS next 5Y - 52W High Chg -44.00%
Recommedations 2.00 Quick Ratio 4.36 Shares Outstanding 119.08M 52W Low Chg 59.00%
Insider Own 31.42% ROA -36.44% Shares Float 81.64M Beta 1.45
Inst Own 15.28% ROE -169.81% Shares Shorted/Prior 3.94M/3.78M Price 3.12
Gross Margin - Profit Margin - Avg. Volume 489,420 Target Price 7.50
Oper. Margin - Earnings Date May 10 Volume 768,639 Change -2.80%
About Humacyte, Inc.

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Humacyte, Inc. News
03/26/24 Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024
03/23/24 Humacyte, Inc. (NASDAQ:HUMA) Q4 2023 Earnings Call Transcript
03/22/24 Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
03/18/24 Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024
03/01/24 Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference
02/29/24 Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock
02/29/24 Humacyte, Inc. Announces Proposed Public Offering of Common Stock
02/09/24 Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
12/12/23 Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel™ (HAV™) for the Treatment of Vascular Trauma
11/24/23 Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference
11/17/23 Humacyte Announces Two Presentations at the VEITHsymposium® of Positive Clinical Results of the Human Acellular Vessel™ (HAV™) in the Treatment of Vascular Trauma
11/14/23 Sidoti Events, LLC’s Virtual November Micro-Cap Conference
11/09/23 Humacyte Third Quarter 2023 Financial Results and Business Update
11/02/23 Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 9, 2023
10/16/23 Humacyte Publishes Preclinical Results Showing Human Acellular Vessel™ (HAV™) Patency as Modified Blalock–Taussig–Thomas Shunt in Juvenile Primate Model
10/02/23 Several Insiders Invested In Humacyte Flagging Positive News
09/23/23 'Politicians have too much power': Sen. Tommy Tuberville recently disclosed $250K in agriculture futures — all while he's been influencing farming industry policies
09/21/23 Humacyte to Present at the Cantor Global Healthcare Conference
09/18/23 Humacyte to Host In-Person KOL Event at the New York EDITION on September 20, 2023
09/12/23 Humacyte Announces Positive Top Line Results from Phase 2/3 Trial of Human Acellular Vessel™ (HAV™) in Treatment of Patients with Vascular Trauma
HUMA Chatroom

User Image tc_tc_tc Posted - 50 minutes ago

$HUMA Mayo Clinic presentation april 27th Humacyte ..

User Image tc_tc_tc Posted - 50 minutes ago

$HUMA Mayo Clinic presentation april 27th Humacyte

User Image forgottenchuck Posted - 9 hours ago

another winner $HUMA

User Image El_Fergusino Posted - 10 hours ago

$HUMA https://youtube.com/shorts/Ndrpy43qstw?si=R9maxTDoWCpDu5Ib

User Image El_Fergusino Posted - 1 day ago

@Bullishbruk check out $HUMA

User Image forgottenchuck Posted - 1 day ago

$HUMA wow

User Image Hagler Posted - 1 day ago

$HUMA Humacyte Note Talk to any parent of a child diagnosed with Tetralogy of Fallot and you will hear just how painful this condition can be. A preclinical study published in #JTCVS signaled that our small-diameter Human Acellular Vessel™ (HAV™) could have the potential to treat this condition.

User Image tc_tc_tc Posted - 1 day ago

$HUMA HUMACYTE plugging the HAV ..few minutes ago

User Image Erikg19 Posted - 1 day ago

$HUMA Looks ready for a move back to highs nearing $5. I like the potential for 2x in the coming weeks. GL

User Image flyinghollaender Posted - 1 day ago

$XFOR what a roller coaster. We'll see how it ends. I have a good feeling. Still holding 5 thousand shares with avg. 0.65 . Already sold 15k shares with an avg price of 1.33$. $ADAP $HUMA bright weeks & months ahead! $MIST planning to use my earnings or losses from XFOR to buy more. $KRON will buy more at a later state.

User Image filodendron Posted - 1 day ago

$HUMA $5-$6 handle in June

User Image Saturno Posted - 1 day ago

$HUMA come on. Everything 5% and you stuck here,.. ?..

User Image filodendron Posted - 1 day ago

$HUMA $4-$5 handle in May

User Image FrankWhite2725 Posted - 1 day ago

$HUMA this thing is afraid to go north of 4

User Image salmonbrain Posted - 1 day ago

$HUMA

User Image CliffordCapital Posted - 1 day ago

$HUMA 4.50$ COME ON!!

User Image FatherofTrades Posted - 1 day ago

$SLS $HUMA $ICU $FRGT I’m holding here, that selling pressure is WEAK at 1.05ish

User Image FatherofTrades Posted - 1 day ago

$SLS $HUMA $ICU $FRGT heavy selling pressure, holding here.

User Image FatherofTrades Posted - 1 day ago

$SLS $HUMA $ICU $FRGT done scaling in

User Image FatherofTrades Posted - 1 day ago

$SLS $HUMA $ICU Today is $FRGT scale in 1.16 beginning.

User Image FatherofTrades Posted - 1 day ago

$HUMA I believe this falls a bit from here. Big money doesn’t own enough. They will shake us out a little to get more. I, personally, will be adding HEAVILY the next time this dips. I’ve been in HUMA for about 2 years now, and believe we are CLOSE! If anything will show how much I believe here, my core position is up nearly 100% and I haven’t sold a share. August is close, but until then… I’ll just day trade and add to my other long positions. Holding a few thousand for this drop. The upside is CLEAR!

User Image Tano4 Posted - 1 day ago

$HUMA excited to see this company get approval in the coming months No more stock offerings needed after that. LFG!

User Image shaveapenny Posted - 1 day ago

$HUMA Tried buying yesterday at $3.82 and got closed out. Going back in for more shares today. I believe this is a multi-bagger with huge benefits to mankind!

User Image FatherofTrades Posted - 1 day ago

$SLS $HUMA $ICU You know the drill, posting a day trade between 930-10AM EST. Let’s scale in AND out beautifully today! I love hearing about you all profiting off these trades! Makes me happy 😊

User Image Saturno Posted - 2 days ago

$HUMA come on guys buy in small packages, lets put this at 4 today.. 🤑🤑

User Image Saturno Posted - 2 days ago

$HUMA well well, looks like this is ready for the next leg?.. over 4 this time to get ready for approval?.. 🤑

User Image filodendron Posted - 2 days ago

$HUMA

User Image Phillvsthemarket Posted - 2 days ago

$HUMA @PatSoonDiggler @Jtredarts Gentleman if approved what is the revenue expect for 2024 year end and 2025 ? They just did an offering and some day we have cash for until H1 2025 . So I expect no more dilution. Is the market for the product which will be approved big ? Thanks,

User Image FatherofTrades Posted - 2 days ago

$SLS $HUMA $ICU Since I’ve been posting these day trades it occurred to me that I should talk about scaling in and out. What is scaling, and why should we do it? Scaling in is the process of placing several small buy limits to purchase share blocks. This happens fast when daytrading volatile tickers, but can help to mitigate risk. I normally scale in for 2-5 minutes on a day trade, generally buying over the course of 3-5 transactions to achieve a low average. Scaling out is the same principle, but applied to selling. Let’s say you buy a stock for a day trade at 2.37 (what todays first buy was). If it drops to 2.22 right after, you’re done. But, if only 20-25% was bought at 2.37, and the rest is bought at 2.19-2.22, then you’re overall up at 2.30 despite your first buy being at 2.37. If the stock rises as you’re scaling in, you lose some gain potential, but by doing this you are protecting yourself from more downside in the event the ask wall is chewed through in the volatility. SAFETY 1ST!

User Image FatherofTrades Posted - 2 days ago

$SLS $ICU $HUMA this is why we SCALE IN and OUT! I bought at 2.37 first buy, added 4 more blocks under that, then sold it off in 2 blocks as I saw it tick higher on Yahoo Finance's live charts. Managing risk at the cost of gains while day trading is worth it!

Analyst Ratings
Cantor Fitzgerald Overweight Apr 1, 24
Piper Sandler Neutral Mar 26, 24
Benchmark Buy Mar 25, 24
Piper Sandler Neutral Mar 8, 24
Benchmark Buy Dec 27, 23
HC Wainwright & Co. Buy Dec 11, 23
Piper Sandler Neutral Nov 10, 23
Cantor Fitzgerald Overweight Sep 21, 23
Cantor Fitzgerald Overweight Aug 31, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Niklason Laura E President, CEO and D.. President, CEO and Director Aug 17 Sell 3.55 1,799,596 6,388,566 8,191,140 08/21/23
Dougan Brady W Director Director Aug 17 Sell 3.55 1,799,596 6,388,566 8,191,140 08/21/23
Ayabudge LLC 10% Owner 10% Owner Aug 17 Sell 3.55 1,799,596 6,388,566 8,191,140 08/21/23
Niklason Laura E President, CEO and D.. President, CEO and Director May 25 Sell 2.75 2,625,000 7,218,750 15,365,736 05/26/23
Prichard Heather Ledbetter Chief Operating Offi.. Chief Operating Officer May 24 Sell 3.99 23,402 93,374 64,566 05/26/23
Prichard Heather Ledbetter Chief Operating Offi.. Chief Operating Officer May 24 Option 1.19 78,779 93,747 74,179 05/26/23
Dougan Brady W Director Director May 25 Sell 2.75 2,625,000 7,218,750 15,365,736 05/26/23
Ayabudge LLC 10% Owner 10% Owner May 25 Sell 2.75 2,625,000 7,218,750 15,365,736 05/26/23
Sander Dale A. CFO and Chief Corp... CFO and Chief Corp. Deve. Off. Dec 13 Buy 2.6 20,000 52,000 20,600 12/19/22
Niklason Laura E President, CEO and D.. President, CEO and Director Dec 15 Buy 2.54 10,000 25,400 1,170,240 12/19/22
Dougan Brady W Director Director Dec 15 Buy 2.54 10,000 25,400 1,170,240 12/19/22
Niklason Laura E President, CEO and D.. President, CEO and Director Dec 16 Sell 2.53 239,538 606,031 17,990,736 12/19/22
Dougan Brady W Director Director Dec 16 Sell 2.53 239,538 606,031 17,990,736 12/19/22
Ayabudge LLC 10% Owner 10% Owner Dec 16 Sell 2.53 239,538 606,031 17,990,736 12/19/22
Scheessele William John Chief Commercial Off.. Chief Commercial Officer Dec 13 Buy 3.09 5,000 15,450 15,525 12/15/22
Niklason Laura E President, CEO and D.. President, CEO and Director Dec 13 Sell 2.74 699,730 1,917,260 18,230,274 12/15/22
Dougan Brady W Director Director Dec 13 Sell 2.74 699,730 1,917,260 18,230,274 12/15/22
Ayabudge LLC 10% Owner 10% Owner Dec 13 Sell 2.74 699,730 1,917,260 18,230,274 12/15/22
Binder Gordon M Director Director Sep 01 Buy 4 48,159 192,636 48,159 09/01/22
Scheessele William John Chief Commercial Off.. Chief Commercial Officer May 24 Buy 4.72 10,525 49,678 10,525 05/25/22
Dougan Brady W Director Director May 23 Buy 4.83 10,000 48,300 1,158,240 05/25/22
Niklason Laura E President, CEO and D.. President, CEO and Director May 23 Buy 4.83 10,000 48,300 1,158,240 05/25/22
Constantino Michael T. Director Director May 23 Buy 4.83 2,000 9,660 4,500 05/24/22
Sander Dale A. CFO and Chief Corp... CFO and Chief Corp. Deve. Off. May 17 Buy 4.53 2,000 9,060 2,000 05/18/22
Dougan Brady W Director Director Dec 14 Sell 9.25 300,000 2,775,000 510,161 12/16/21
Niklason Laura E President, CEO and D.. President, CEO and Director Dec 14 Sell 9.25 300,000 2,775,000 510,161 12/16/21
Constantino Michael T. Director Director Nov 22 Buy 10.81 2,500 27,025 2,500 11/24/21